Discover breaking news about Dynasil

Press Releases

 

February 13, 2017

Dynasil Corporation of America Reports First Quarter Fiscal 2017 Recognition of Deferred Tax Asset Benefit of $2.7 million

Newton, MA, February 13, 2017 – Dynasil Corporation of America (NASDAQ: DYSL), a developer and manufacturer of optics and photonics products, optical detection and analysis technology and components for the homeland security, medical and industrial markets, today announced earnings attributable to common stockholders of $2.8 million or $0.17 per common share for the first quarter of the 2017 fiscal year, largely as the result of a U.S. income tax benefit resulting from the deconsolidation for tax purposes of Xcede Technologies, Inc., the Company’s tissue sealant technology development joint venture.

February 10, 2017

Dynasil Corporation Schedules First Quarter Fiscal 2017 Financial Results Conference Call

Company to Webcast Conference Call Live at 5:00 p.m. ET on February 14

Newton, Mass., February 9, 2017 – Dynasil Corporation of America (NASDAQ: DYSL) plans to release financial results for the fiscal quarter ended December 31, 2016 on Monday, February 13 and management will host a conference call for investors and analysts the following day, February 14, 2017 at 5:00 p.m. ET.

December 21, 2016

Dynasil Reports Fiscal Year 2016 Financial Results

Newton, MA, December 21, 2016 – Dynasil Corporation of America (NASDAQ: DYSL), a developer and manufacturer of optics and photonics products, optical detection and analysis technology and components for the homeland security, medical and industrial markets, today announced net income of $0.3 million and $0.04 per common share for the fiscal year ended September 30, 2016 and the filing of its Annual Report on Form 10-K.

NIH logo

November 29, 2016

Dynasil’s RMD Awarded $1.9 Million in Technology Development Grants by The National Institute of Health

Newton, MA, November 29, 2016 – Dynasil Corporation of America (NASDAQ: DYSL) today announced that its contract research subsidiary, RMD Inc., has received three Phase I and one Phase II grants totaling $1.9 million under the National Institute of Health’s SBIR funding program.

Xcede Technologies patch

November 18, 2016

Dynasil Corporation and Cook Biotech Inc. Join Together to Advance Xcede Technologies Patch through First in Human Trials

Rochester, Minn., Nov 18, 2016 – Dynasil Corporation of America (NASDAQ: DYSL) today announced that it has made a commitment for a further $1.2 million investment in subsidiary Xcede Technologies, Inc. This investment comes alongside a commitment from Cook Biotech Inc. (CBI) of West Lafayette, Ind., to manage the Xcede Patch first-in-human clinical study on behalf of Xcede in exchange for secured loan considerations of up to $1.5 million. In addition, Peter Sulick, Dynasil Chairman and CEO, and members of his family made an additional investment of $450,000. It is anticipated this $3.15 million funding will be sufficient for Xcede to complete first-in-human clinical trials and related preclinical tests. The preclinical studies are anticipated to begin in 2016 and the trial in 2017.

Hand holding the Thermo RadEye SPRD-GN.

November 2, 2016

Dynasil’s RMD Supplying Thermo Fisher Scientific with CLYC for New RadEye SPRD-GN Detector

Newton, MA., November 2, 2016 – Dynasil Corporation of America (NASDAQ: DYSL) today announced that its subsidiary, RMD Inc., will be supplying Thermo Fisher Scientific with packaged solid state detectors based on RMD’s Cs2LiYCl6:Ce (CLYC) scintillation crystals for use in Thermo’s new RadEye SPRD-GN spectroscopic personal radiation detectors.

Tunable Light Sources

September 4, 2016

Opportunities in Automotive Head-Up Display (HUD) Market

Thurna ut justo auctor accumsan. Sed velit enim, malesuada nec felis et, ultricies metus donec consectetur bibendum placerat pellentesque malesuada. tellus nibh, vel molestie sapien dapibus.

US Department of Energy

August 22, 2016

Dynasil’s RMD Awarded $1.86 Million in Technology Development Grants by U.S. DOE

Newton, MA, August 23, 2016 –Dynasil Corporation of America (NASDAQ: DYSL) today announced that its contract research subsidiary, RMD Inc., has received grants totaling $1.86 million under the U.S. Department of Energy’s Small Business Innovation Research (SBIR) and Small Business Technology Transfer (STTR) Programs.

RMD is finalist for R&D 100 Awards 2016

August 17, 2016

Dynasil’s RMD is Finalist for R&D 100 Awards

Newton, MA, August 17, 2016 –Dynasil Corporation of America (NASDAQ: DYSL) today announced that its contract research subsidiary, RMD Inc., was selected as a finalist for the R&D 100 awards.

August 11, 2016

Dynasil Reports Revenue Up 11%

Newton, MA, August 11, 2016 – Dynasil Corporation of America (NASDAQ: DYSL), a developer and manufacturer of optics and photonics products, optical detection and analysis technology and components for the homeland security, medical and industrial markets, today announced its 2016 nine month year to date revenue is $32.9 million compared to $29.8 million in the same nine month period of 2015. This $3.1 million represents an increase of 11% in 2016 primarily driven by our Optics segment businesses.

Save & Share Cart
Your Shopping Cart will be saved and you'll be given a link. You, or anyone with the link, can use it to retrieve your Cart at any time.
Back Save & Share Cart
Your Shopping Cart will be saved with Product pictures and information, and Cart Totals. Then send it to yourself, or a friend, with a link to retrieve it at any time.
Your cart email sent successfully :)